EU Clears GSK-Pfizer Joint Venture With Conditions
The European Commission said it has approved pharmaceutical giants GlaxoSmithKline and Pfizer's multibillion-dollar joint consumer health care venture, if Pfizer sells off its topical pain management business under its ThermaCare brand....To view the full article, register now.
Already a subscriber? Click here to view full article